Cervical Swede score screening by colposcope and the Gynocular

ISRCTN ISRCTN53264564
DOI https://doi.org/10.1186/ISRCTN53264564
Secondary identifying numbers N/A
Submission date
13/09/2013
Registration date
20/01/2014
Last edited
03/07/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Urological and Genital Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
A colposcope is a microscope which is adapted for vaginal examination and helps doctors to detect abnormal areas on the cervix that might harbour the early stages of cervical cancer. This study aims to find out if a battery-driven handheld colposcope, the Gynocular, is equally good at detecting cervical lesions as a stationary colposcope.

Who can participate?
Women referred for colposcopy at the Colposcopy Clinic of Bangabandhu Sheikh Mujib Medical University (BSMMU).

What does the study involve?
Participants were randomly allocated to one of two groups: the participants in Group 1 were screened using the Gynocular and the participants in Group 2 were screened using the stationary device. Participants then swapped over - those allocated to Group 1 were examined with the stationary colposcope and Group 2 were examined using the Gynocular. All women found to have cervical lesions were offered treatment at BSMMU.

What are the possible benefits and risks of participating?
Participating in the study involved no side effects. There were no risks of participating. If a women chose not to participate, she had a standard method of examination.

Where is the study run from?
The study ran from the Department of Colposcopy, BSMMU, Dhaka, Bangladesh.

When is the study starting and how long is it expected to run for?
The study started in June 2012 and ended in September 2013.

Who is funding the study?
The study was funded by Gynius AB (Sweden) and H&M Conscious Foundation (Sweden).

Who is the main contact?
Prof Ashrafun Nessa
ashra58@yahoo.co.uk

Contact information

Prof Ashrafun Nessa
Scientific

Department of Obstetrics and Gynecology
Bangabandhu Sheikh Mujib Medical University Hospital (BSMMU)
Shabag
Dhaka
1000
Bangladesh

Study information

Study designCrossover randomized clinical trial
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Hospital
Study typeScreening
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe Bangladesh Swede score Gynocular clinical trial
Study objectivesCervical Swede score as an alternative cervical screening approach in low-resource settings by using a pocket-sized battery-driven colposcope, the Gynocular.
Ethics approval(s)The study was approved by the local ethics committees in Bangladesh and in Sweden:
1. The Institutional Review Board of BSMMU (Dnr BSMMU/2012/3176)
2. Stockholm Regional Ethical Review Board (Dnr 2012/545-31/1)
Health condition(s) or problem(s) studiedCervical screening
Colposcopy
Swede score
InterventionPatients were randomized to two groups:
Group 1 were examined with the hand-held colposcope, the Gynocular
Group 2 were examined with a stationary colposcope

Participants were then crossed over. Those randomized to Group 1 were examined with the stationary colposcope and Group 2 were examined using the Gynocular. Women who had a positive cytology or cervical biopsy with high-grade cervical dysplasia were offered treatment at BSMMU.
Intervention typeDevice
Pharmaceutical study type(s)
Phase
Drug / device / biological / vaccine name(s)
Primary outcome measureCompare if a hand-held colposcope, the Gynocular, could detect cervical lesions equal to a stationary colposcope
Secondary outcome measuresTo evaluate the performance of Swede score to detect cervical lesions in VIA-positive women, and detection rates of HPV
Overall study start date01/06/2012
Completion date15/09/2013

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participants540
Key inclusion criteria1. Women positive for acetic acid (VIA) at opportunistic screening by trained family welfare visitors, senior staff nurses and doctors in the Dhaka region, Bangladesh, referred for colposcopy at the Colposcopy Clinic of Bangabandhu Sheikh Mujib Medical University (BSMMU). A women is considered to be VIA positive when a trained doctor or nurse noticed sharp, distinct, well defined, dense acetowhite areas on the cervix, with or without raised margins, close to the squamocolumnar junction (SCJ) in the transformation zone 6-9, 15.
2. Women signing an informed consent to participate in the study after receiving oral and written information from a social worker
3. Ability to understand written and oral information
Key exclusion criteria1. Ongoing vaginal bleeding
2. Any previous gynecological examinations for at least one week before
3. Pregnancy
Date of first enrolment01/06/2012
Date of final enrolment15/09/2013

Locations

Countries of recruitment

  • Bangladesh

Study participating centre

Bangabandhu Sheikh Mujib Medical University Hospital (BSMMU)
Dhaka
1000
Bangladesh

Sponsor information

Gynius AB (Sweden)
Industry

Döbelnsgatan 40
Stockholm
111 40
Sweden

ROR logo "ROR" https://ror.org/04ykj1118

Funders

Funder type

Industry

Gynius AB (Sweden)

No information available

H&M Conscious Foundation (Sweden)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 03/11/2014 Yes No